Literature DB >> 18550794

Expression and function of PDCD1 at the human maternal-fetal interface.

Elizabeth S Taglauer1, Ann S Trikhacheva, Joyce G Slusser, Margaret G Petroff.   

Abstract

The failure to reject the semiallogenic fetus by maternal T lymphocytes suggests that potent mechanisms regulate these cells. PDCD1 is a CD28 family receptor expressed by T cells, and its ligand CD274 is strongly expressed by trophoblast cells of the human placenta. In this study, we examined whether human maternal T cells express PDCD1. Immunofluorescence examination of uterine tissues revealed PDCD1 expression on CD3+ cells was low in nonpregnant endometrium but increased in first-trimester decidua and remained elevated in term decidua (P < 0.05). In addition, higher relative proportions of term decidual CD8 bright, CD4+, and regulatory T cells expressed PDCD1 in comparison to autologous peripheral blood (P < 0.05). Term decidual T cells also expressed full-length and soluble PDCD1 mRNA isoforms more abundantly than their peripheral blood counterparts (P <or= 0.05). We also examined the effects of PDCD1:CD274 interactions in decidual T cells. Jar choriocarcinoma cells were transfected with CD274 and cocultured with activated decidual CD4+ or CD8 bright T cells for 72 h followed by analysis of cytokine concentration and decidual T cell apoptosis. Compared with empty vector-transfected cells, CD274-transfected Jar cells caused a significant suppression of interferon gamma and tumor necrosis factor alpha production by CD4+ (P < 0.05) but not CD8 bright T cells, while having no effect on secretion of IL10 or T cell apoptosis. These results suggest that the PDCD1:CD274 pathway functions in modification of maternal decidual lymphocyte cytokine secretion during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550794      PMCID: PMC2688813          DOI: 10.1095/biolreprod.107.066324

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  56 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.

Authors:  Jun Yang; Joyce Popoola; Shakila Khandwala; Nidyanandh Vadivel; Vijay Vanguri; Xueli Yuan; Shirine Dada; Indira Guleria; Chaorui Tian; M Javeed Ansari; Tahiro Shin; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Anil Chandraker
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

3.  Evidence of a T(H) 1 type response associated with recurrent miscarriage.

Authors:  C Jenkins; J Roberts; R Wilson; M A MacLean; J Shilito; J J Walker
Journal:  Fertil Steril       Date:  2000-06       Impact factor: 7.329

4.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

5.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  Elevated expression of activation molecules by decidual lymphocytes in women suffering spontaneous early pregnancy loss.

Authors:  N Vassiliadou; R F Searle; J N Bulmer
Journal:  Hum Reprod       Date:  1999-05       Impact factor: 6.918

7.  Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.

Authors:  Liqing Wang; Rongxiang Han; Wayne W Hancock
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

8.  PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.

Authors:  Mary E Keir; Gordon J Freeman; Arlene H Sharpe
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.

Authors:  A A Ashkar; J P Di Santo; B A Croy
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  28 in total

1.  Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Authors:  Antoine L Perchellet; Susmita Jasti; Margaret G Petroff
Journal:  Biol Reprod       Date:  2013-10-31       Impact factor: 4.285

Review 2.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 3.  B7 family molecules as regulators of the maternal immune system in pregnancy.

Authors:  Margaret G Petroff; Antoine Perchellet
Journal:  Am J Reprod Immunol       Date:  2010-04-08       Impact factor: 3.886

4.  Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity.

Authors:  Anita van der Zwan; Kevin Bi; Errol R Norwitz; Ângela C Crespo; Frans H J Claas; Jack L Strominger; Tamara Tilburgs
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-19       Impact factor: 11.205

Review 5.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

6.  PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.

Authors:  Emanuela Veras; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2017-03       Impact factor: 2.762

7.  Immunomodulatory molecules are released from the first trimester and term placenta via exosomes.

Authors:  S K Kshirsagar; S M Alam; S Jasti; H Hodes; T Nauser; M Gilliam; C Billstrand; J S Hunt; M G Petroff
Journal:  Placenta       Date:  2012-10-26       Impact factor: 3.481

8.  Differentiation-induced post-transcriptional control of B7-H1 in human trophoblast cells.

Authors:  L M Holets; M Z Carletti; S K Kshirsagar; L K Christenson; M G Petroff
Journal:  Placenta       Date:  2008-11-17       Impact factor: 3.481

9.  Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy.

Authors:  Elizabeth S Taglauer; Thomas M Yankee; Margaret G Petroff
Journal:  J Reprod Immunol       Date:  2009-04-14       Impact factor: 4.054

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.